"Registration of the vaccine is expected next year," Interfax quotes the agency's specialists who work at the Eastern Economic Forum (EEF).
It is clarified that at the moment 200 people aged from 18 to 60 are participating in clinical trials.
FMBA officials said the volunteers had no side effects from vaccinations.
In July, the Federal Biomedical Agency developed and registered a new test system for detecting the most relevant strains of coronavirus.